Plaintiff: Tawnsaura Group
Defendant: Direct Digital
Case
Number: 8:13-cv-00004
Date Filed: January 02, 2013
Court: California Central District Court
Patents-in-Suit: US5874471 and US6028107
Patent Number
Current
Assignee[*]
|
Issued Date
|
Expiration Date[†]
|
Title
|
|
|
Feb 23, 1999
|
Feb 27, 2017
|
Orthomolecular medical use of L-citrulline
for vasoprotection, relaxative smooth muscle tone and cell protection
|
|
|
Feb 22, 2000
|
Feb 27, 2017
|
Orthomolecular medical use of L-citrulline
for vasoprotection, relaxative smooth muscle tone and cell protection
|
Table information sourced from
Maxval’s Assignment
Database.
The ‘471 patent describes a method of improving human health
to increase the plasma level of arginine which is up to three times an average
overnight fasting level, comprising orally administering a substance selected
from the group consisting of L-citrulline and the calcium salt of L-citrulline.
The
‘107 patent describes a method
of improving human health to increase the
plasma concentration of
arginine comprising orally administering L-citrulline as precursor
substance.
About the Parties:
Tawnsaura
Group is a limited liability company.
Direct
Digital is a direct response company based in
Boston, MA and Charlotte, NC. Direct Digital owns wellness and nutritional
supplements on the market. These brands include Nugenix®, Lumiday®, Luminite®
and Instaflex®.
As in Complaint:
Defendant
advertises that Nugenix products contain ingredients “L-Citrulline" and/or
"L-Citrulline Malate” and "not only boosts testosterone levels via
natural ingredients, but also helps increase, enhance muscle mass and improve
overall body strength. Plaintiff alleges that defendant infringes the '471 and '107
patents by marketing the Nugenix products.
Other Cases Filed:
Plaintiff
has recently filed cases against the following companies:
Defendant
|
Case Number
|
Date Filed
|
Status
|
11/29/2012
|
Pending
|
||
Woodbolt Distribution
|
11/29/2012
|
Pending
|
|
11/15/2012
|
Pending
|
||
11/15/2012
|
Pending
|
||
USP Labs
|
11/15/2012
|
Pending
|
|
11/15/2012
|
Pending
|
||
11/15/2012
|
Pending
|
If
you are interested in knowing more about the cases filed by Tawnsaura, please contact us.
To
get alerts on cases filed, subscribe to our Litigation Alerts.
[*] MaxVal offers Patent Assignment Alert service where subscribers
receive email alerts when assignments relating to target applications, patents
or entities of interest are recorded.
[†] Expected expiration date. Patent Term
Estimator is a free web-based tool that automatically calculates patent terms and
expiration dates for U.S. utility patents.
No comments:
Post a Comment